Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray
Background Intranasal corticosteroids (INS) are recommended as first-line therapy for allergic rhinitis. To date, no studies have evaluated the impact of an INS delivery system on patient satisfaction. Unless patients use a medication appropriately and consistently, they will not fully benefit from...
Main Authors: | Leonard M. Fromer, Gabriel R. Ortiz, April M. Dowdee |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2008-01-01
|
Series: | World Allergy Organization Journal |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1939455119305903 |
Similar Items
-
A Patient Preference Study that Evaluated Fluticasone Furoate and Mometasone Furoate Nasal Sprays for Allergic Rhinitis
by: Anahi Yanez M.D., et al.
Published: (2016-10-01) -
Evaluation of rheological and mucoadhesive properties of selected nasal spray preparations with mometasone furoate
by: Emilia Szymańska, et al.
Published: (2017-06-01) -
Development of simple and fast UV-method for the quantitative determination of mometasone furoate in a large number of metered doses of an aqueous nasal spray of mometasone furoate
by: Mykhaylo Levin, et al.
Published: (2019-11-01) -
Comparison of montelukast and mometasone furoate in the prevention of recurrent nasal polyps
by: Erkan Vuralkan, et al.
Published: (2012-02-01) -
Clinical efficacy and tolerability of mometasone furoate nasal spray in perennial allergic rhinitis patients : an open multicentre study
by: Iwan Darmansjah, et al.
Published: (2002-05-01)